DK2452944T3 - Diphenylsulfidderivater samt lægemidler indeholdende dem som aktivt stof - Google Patents

Diphenylsulfidderivater samt lægemidler indeholdende dem som aktivt stof

Info

Publication number: DK2452944T3
Authority: DK; Denmark
Prior art keywords: well; active substance; drugs containing; diphenylsulfide; derivatives
Prior art date: 2009-07-09

Application number

DK10796915.6T

Other languages

English (en)

Inventor

Yasushi Kohno

Kiyoshi Fujii

Momoko Taru

Keita Miyoshi

Original Assignee

Kyorin Seiyaku Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-07-09

Filing date

2010-07-08

Publication date

2014-10-27

2010-07-08 Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk

2014-10-27 Application granted granted Critical

2014-10-27 Publication of DK2452944T3 publication Critical patent/DK2452944T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4015—Esters of acyclic unsaturated acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Pulmonology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Diabetes (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK10796915.6T 2009-07-09 2010-07-08 Diphenylsulfidderivater samt lægemidler indeholdende dem som aktivt stof DK2452944T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2009162289		2009-07-09
JP2010112138		2010-05-14
PCT/JP2010/004453 WO2011004604A1 (ja)	2009-07-09	2010-07-08	ジフェニルスルフィド誘導体及びそれらを有効成分とする医薬

Publications (1)

Publication Number	Publication Date
DK2452944T3 true DK2452944T3 (da)	2014-10-27

Family

ID=43429031

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK10796915.6T DK2452944T3 (da)	2009-07-09	2010-07-08	Diphenylsulfidderivater samt lægemidler indeholdende dem som aktivt stof

Country Status (20)

Country	Link
US (1)	US8569270B2 (da)
EP (1)	EP2452944B1 (da)
JP (1)	JP5616342B2 (da)
KR (1)	KR20120089234A (da)
CN (1)	CN102471355B (da)
AU (1)	AU2010269668B2 (da)
BR (1)	BR112012000320A2 (da)
CA (1)	CA2764126A1 (da)
DK (1)	DK2452944T3 (da)
ES (1)	ES2514665T3 (da)
HK (1)	HK1171234A1 (da)
HR (1)	HRP20141065T1 (da)
MX (1)	MX2011013182A (da)
NZ (1)	NZ596605A (da)
PL (1)	PL2452944T3 (da)
PT (1)	PT2452944E (da)
SG (1)	SG176573A1 (da)
SI (1)	SI2452944T1 (da)
WO (1)	WO2011004604A1 (da)
ZA (1)	ZA201108459B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI519539B (zh) *	2010-12-21	2016-02-01	Kyorin Seiyaku Kk	Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient thereof
CN102863345A (zh) *	2011-07-06	2013-01-09	中国医学科学院药物研究所	胺基丙二醇类衍生物、其制备方法和其药物组合物与用途
WO2015194157A1 (ja) *	2014-06-16	2015-12-23	杏林製薬株式会社	ジフェニルスルフィド誘導体の製造方法及び製造中間体
CN110357773A (zh) *	2019-07-08	2019-10-22	南通嘉禾化工有限公司	3-氯-4-羟基苯甲酸的合成
CN113754613B (zh) *	2021-09-27	2023-06-30	北京工商大学	一种4-烯醇的苯硫基环醚化方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003020313A1 (fr)	2001-09-04	2003-03-13	Ono Pharmaceutical Co., Ltd.	Medicaments contre les maladies respiratoires renfermant un agent de regulation du recepteur de la sphingosine-1-phosphate
EP1431275B1 (en)	2001-09-27	2010-04-07	Kyorin Pharmaceutical Co., Ltd.	Diaryl ether derivative, addition salt thereof, and immunosuppressant
CA2461212C (en)	2001-09-27	2010-08-17	Kyorin Pharmaceutical Co., Ltd.	Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
BR0314455A (pt)	2002-09-19	2005-07-26	Kyorin Seiyaku Kk	Derivados de aminoálcool, seus sais e agentes imunosupressores
CA2515574C (en) *	2003-02-18	2012-03-13	Kyorin Pharmaceutical Co., Ltd.	Aminophosphonic acid derivative, salt thereof, and modulator of s1p receptor
SA04250253B1 (ar)	2003-08-21	2009-11-10	استرازينيكا ايه بي	احماض فينوكسي اسيتيك مستبدلة باعتبارها مركبات صيدلانية لعلاج الامراض التنفسية مثل الربو ومرض الانسداد الرئوي المزمن
WO2005044780A1 (ja)	2003-11-10	2005-05-19	Kyorin Pharmaceutical Co., Ltd.	アミノカルボン酸誘導体とその付加塩及びｓ１ｐ受容体調節剤
JP2005247691A (ja)	2004-03-01	2005-09-15	Toa Eiyo Ltd	Ｓ１ｐ３受容体拮抗薬
US7888527B2 (en)	2004-12-06	2011-02-15	University Of Virginia Patent Foundation	Aryl amide sphingosine 1-phosphate analogs
WO2007043568A1 (ja)	2005-10-12	2007-04-19	Toa Eiyo Ltd.	Ｓ１ｐ３受容体拮抗剤
US20090318389A1 (en) *	2006-08-04	2009-12-24	Praecis Pharmaceuticals Incorporated	Agonists of the sphingosine-1 phosphate receptor
MY152176A (en)	2006-08-08	2014-08-15	Kyorin Seiyaku Kk	Amino phosphate derivative and s1p receptor modulator having same as an active ingredient
JP2008239546A (ja) *	2007-03-27	2008-10-09	Kyorin Pharmaceut Co Ltd	アミノアルコール誘導体及びそれらを有効成分とする免疫抑制剤
JP2010013407A (ja) *	2008-07-04	2010-01-21	Kyorin Pharmaceut Co Ltd	アミノアルコール誘導体
JP2010077053A (ja) *	2008-09-25	2010-04-08	Kyorin Pharmaceut Co Ltd	フェノール誘導体及びそれらを有効成分とする医薬

2010
- 2010-07-08 NZ NZ596605A patent/NZ596605A/xx not_active IP Right Cessation
- 2010-07-08 MX MX2011013182A patent/MX2011013182A/es active IP Right Grant
- 2010-07-08 PL PL10796915T patent/PL2452944T3/pl unknown
- 2010-07-08 AU AU2010269668A patent/AU2010269668B2/en not_active Ceased
- 2010-07-08 JP JP2011521823A patent/JP5616342B2/ja not_active Expired - Fee Related
- 2010-07-08 SG SG2011085511A patent/SG176573A1/en unknown
- 2010-07-08 DK DK10796915.6T patent/DK2452944T3/da active
- 2010-07-08 SI SI201030811T patent/SI2452944T1/sl unknown
- 2010-07-08 CN CN201080030630.3A patent/CN102471355B/zh not_active Expired - Fee Related
- 2010-07-08 WO PCT/JP2010/004453 patent/WO2011004604A1/ja active Application Filing
- 2010-07-08 EP EP10796915.6A patent/EP2452944B1/en active Active
- 2010-07-08 US US13/382,011 patent/US8569270B2/en active Active
- 2010-07-08 ES ES10796915.6T patent/ES2514665T3/es active Active
- 2010-07-08 BR BR112012000320A patent/BR112012000320A2/pt not_active IP Right Cessation
- 2010-07-08 PT PT107969156T patent/PT2452944E/pt unknown
- 2010-07-08 CA CA2764126A patent/CA2764126A1/en not_active Abandoned
- 2010-07-08 KR KR1020127003551A patent/KR20120089234A/ko active IP Right Grant
2011
- 2011-11-17 ZA ZA2011/08459A patent/ZA201108459B/en unknown
2012
- 2012-11-21 HK HK12111884.2A patent/HK1171234A1/zh not_active IP Right Cessation
2014
- 2014-11-03 HR HRP20141065AT patent/HRP20141065T1/hr unknown

Also Published As

Publication number	Publication date
HK1171234A1 (zh)	2013-03-22
EP2452944B1 (en)	2014-09-10
ZA201108459B (en)	2012-07-25
SG176573A1 (en)	2012-01-30
PT2452944E (pt)	2014-10-13
EP2452944A4 (en)	2013-04-03
JP5616342B2 (ja)	2014-10-29
BR112012000320A2 (pt)	2016-03-22
PL2452944T3 (pl)	2015-03-31
AU2010269668B2 (en)	2013-12-19
CA2764126A1 (en)	2011-01-13
SI2452944T1 (sl)	2015-01-30
US20120101068A1 (en)	2012-04-26
WO2011004604A1 (ja)	2011-01-13
CN102471355A (zh)	2012-05-23
JPWO2011004604A1 (ja)	2012-12-20
MX2011013182A (es)	2012-01-31
NZ596605A (en)	2013-09-27
AU2010269668A1 (en)	2011-12-15
US8569270B2 (en)	2013-10-29
EP2452944A1 (en)	2012-05-16
CN102471355B (zh)	2015-10-07
KR20120089234A (ko)	2012-08-09
HRP20141065T1 (hr)	2015-02-13
ES2514665T3 (es)	2014-10-28

Publication	Publication Date	Title
DK3124483T3 (da)	2019-09-02	Pyrazolaminopyrimidin-derivater som LRRK2-modulatorer
LT3360575T (lt)	2023-06-12	Transderminės farmacinės kompozicijos, apimančios veiksminguosius agentus
BR112014001255A2 (pt)	2017-02-21	composto, uso de um composto, combinação, e, composição farmacêutica
BR112014013760A2 (pt)	2017-06-13	composto, composição farmacêutica e uso de um composto
DK2234502T4 (da)	2021-10-11	Mikrokapsler, der omfatter et fedtopløseligt aktivt stof
BR112014001346A2 (pt)	2017-07-18	composto nanotransportador, método, composto farmacêutico e uso de um composto
DK2328893T3 (da)	2013-06-17	Triazolforbindelser som modulerer hsp90 aktivitet
IT1394860B1 (it)	2012-07-20	Composti farmaceutici
BR112013008259A2 (pt)	2017-12-12	composto, composição farmacêutica, e, uso de um composto
DK2364293T3 (da)	2013-04-22	Hidtil ukendte pyrazol-4-N-alkoxycarboxamider som mikrobiocider
BR112014029530A2 (pt)	2017-06-27	compostos, composição farmacêutica e uso de um composto
BR112013015397A2 (pt)	2016-09-20	composto, composição farmacêutica, e, uso de um composto
BR112014005669A2 (pt)	2017-04-04	composto, composição farmacêutica e uso de um composto
BR112014014769A2 (pt)	2017-06-13	Composto, composição farmacêutica, e, uso de um composto ou sal.
BR112014001868A2 (pt)	2017-02-21	cápsulas supramoleculares
BR112014003567A2 (pt)	2018-08-14	composto, uso de um composto, e, composição farmacêutica
DK3103797T3 (da)	2019-07-15	2,5-dioxoimidazolidin-1-yl-3-phenylurinstofderivater som formylpeptidreceptor-lignende-1- (fprl-1) receptormodulatorer
BR112013030302A2 (pt)	2017-06-27	composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
IL232035A0 (en)	2014-05-28	Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
DK2513106T3 (da)	2014-01-13	Heteroaromatiske aryltriazol-derivater som pde10a-enzyminhibitorer
BRPI1016190A2 (pt)	2017-03-28	compostos farmacêuticos.
BR112014013177A2 (pt)	2017-06-13	composto, composição farmacêutica e uso de um composto
DK2775986T3 (da)	2021-03-22	Filmemballage til orale biologiske stoffer
BR112014013178A2 (pt)	2017-06-13	composto, composição farmacêutica e uso de um composto
BR112015002824A2 (pt)	2017-08-08	composto, uso de um composto, composição farmacêutica, e, produto farmacêutico de combinação.